As of June 2026, 29 paid clinical trials are recruiting in Sherman Oaks, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Sherman Oaks offers studies at sites including California Neuroscience Research for conditions such as Major Depressive Disorder, Alzheimer Disease, Alzheimers Disease, Psychosis Associated With Alzheimer's Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Sherman Oaks has approximately 29 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Researchers run research studies in Sherman Oaks, CA at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| California Neuroscience Research | Autism Spectrum Disorder, Depressive Disorder, Major, Major Depressive Disorder | 3 |
| Cenexel California Neuroscience Research, LLC | Alzheimers Disease | 2 |
| Local Institution - 1103 | Psychosis Associated With Alzheimer's Disease | 2 |
| Schuster Medical Research Institute | Schizophrenia, Bipolar I Disorder, Bipolar II Disorder | 2 |
| Accellacare - Sherman Oaks | Agitation, Alzheimer Disease | 1 |
| Advanced Dermatology and Skin Cancer Institute - Beverly Hills | Plaque Psoriasis | 1 |
| Amicis Research Center | Chronic Inducible Urticaria, Cold Urticaria, Cold-Induced Urticaria | 1 |
| Baxis | Bacterial Conjunctivitis | 1 |
| CenExel CNR | Major Depressive Disorder | 1 |
| CenExel Sherman Oaks | Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis | 1 |
| Cenexel Cnr - Sherman Oaks | Major Depressive Disorder | 1 |
| Cura Clinical Research | Ankylosing Spondylitis, Autoimmune Diseases, Birdshot Chorioretinitis | 1 |
| GSK Investigational Site | Chickenpox | 1 |
| Genesis Research LLC 1 | Non-Muscle Invasive Bladder Neoplasms | 1 |
| Integrated Clinical Research LLC | Vulvovaginal Candidiases, Vulvovaginal Candidiasis (VVC), Vulvovaginal Candidiasis, Genital | 1 |
| Investigative | Hidradenitis Suppurativa (HS) | 1 |
| Neurocrine Clinical Site | Schizophrenia | 1 |
| Radiance Surgery Center | Lumbar Spinal Stenosis | 1 |
| Unified Health | Angiokeratomas | 1 |
| Unison Clinical Trials | Plaque Psoriasis | 1 |
| Vistagen Clinical Site | Social Anxiety Disorder | 1 |
Recruiting trials in Sherman Oaks grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Hipa.ai aggregates every recruiting study in Sherman Oaks from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 29 recruiting clinical trials in Sherman Oaks, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Sherman Oaks compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Sherman Oaks include Major Depressive Disorder (3), Alzheimer Disease (2), Alzheimers Disease (2), Psychosis Associated With Alzheimer's Disease (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Sherman Oaks on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Sherman Oaks include California Neuroscience Research, Cenexel California Neuroscience Research, LLC, Local Institution - 1103, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Sherman Oaks are Mental health & behavior (5), Neurology & pain (3), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.